Follow us on:
Breaking News
September 4, 2026
CP Direct: Friday Edition
Breaking News
Thermo Fisher_CP_Webinar_Leaderboard_0926

An Insider’s Guide to Reaching a Right-the-First-Time Tech Transfer

 
An Insider’s Guide to Reaching a Right-the-First-Time Tech Transfer

Discover how an experienced CDMO helps sponsors navigate tech transfer right the first time, reducing risk, delays, and costly rework.
Read More >>

Top Headlines

Friday Brief
Videos

The Friday Brief for September 4, 2026: Licensing Deals Dominate the Week

Meanwhile, in acquisitions, Lilly agreed to absorb Merida, and PerkinElmer completed its buyout of SimoTech.

SPONSOR

Used Pharmaceutical Manufacturing and Processing Equipment

Federal Equipment Company has on-hand inventory in more than 200 categories of OEM-brand equipment in clean, climate-controlled warehouses, enabling you to quickly source processing and packaging equipment you need from a supplier with over 60 years of experience.

Breaking News

Curia Opens Expanded New Mexico Manufacturing Campus

$200M investment boosts sterile injectable drug production capacity in Albuquerque.

Breaking News
Collaborations & Alliances

Hutchmed, GSK Ink $1.3B Cancer Drug Deal

GSK gains rights outside Greater China to develop HMPL-A830 for KRAS-altered tumors.

SPONSOR

What's Really Behind FDA CRLs on Cell Based Assays?

Reginald Clayton, PhD, and Daniel Galbraith, PhD, of Solvias break down recent FDA observations on cell based assays into practical steps for biologics, cell therapy, and gene therapy developers. Save your seat now for the free Contract Pharma Webinar on Sept 22.

ContractPharma_Conference_2026_650x250

Breaking News
Collaborations & Alliances

Cipla, Qilu Enter Licensing and Supply Deal for Keytruda Biosimilar in US

Qilu will be responsible for development, regulatory registration, and supply, while Cipla will commercialize the biosimilar.

Breaking News

PerkinElmer Completes SimoTech Acquisition

Deal expands PerkinElmer’s automation, GMP IT and digital manufacturing capabilities for life sciences customers.

SPONSOR

A Smarter Approach to Overcoming OSD Development Challenges

Explore how predictive tools, integrated expertise, and proactive planning can help development teams address risks earlier and bring oral therapies forward more efficiently.

Features

The CDMO Capacity Crunch Persists

Nearly half of biopharma companies report difficulty finding mammalian production capacity, while cell and gene therapy face even tighter constraints.

SPONSOR

Choosing the Right Path to Commercialization

Innovative ways to expand your brand portfolio and bring new products to market.

Featured Resources

Solution Content Center SPOTLIGHT

Vetter Pharma International

Vetter is a leading and independent global CDMO for the aseptic production of injectables. Its roots and headquarters are in Ravensburg, Germany. Vetter has been a stable, reliable family-owned company since its establishment as a pharmacy in 1950, now with more than 7,400 skilled and dedicated employees.

 

Solution Content Center SPOTLIGHT

Adare Pharma Solutions

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Adare’s specialized technology platforms provide taste masking, customized release, multiparticulate systems, and patient-centric dosing solutions. With a proven history in drug delivery, Adare’s facilities in the US and Europe have developed and manufactured more than sixty-five products sold by customers worldwide.